Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Conrad

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Molecular Cancer Therapeutics|April 14, 2005
Bovine lactoferricin selectively induces apoptosis in human leukemia and carcinoma cell linesJamie S Mader, Jayme Salsman, David M Conrad, et al.
Immunology and Cell Biology|July 22, 2005
Antibody blockade of Thy-1 (CD90) impairs mouse cytotoxic T lymphocyte induction by anti-CD3 monoclonal antibodyS M Mansour Haeryfar, David M Conrad, Brucel Musgrave, et al.
International Journal of Oncology|February 23, 2008
Inhibition of T cell and natural killer cell function by adenosine and its contribution to immune evasion by tumor cells (Review)David W Hoskin, Jamie S Mader, Suzanne J Furlong, et al.
Lancet (London, England)|September 28, 2024
Bone marrow necrosis and hyperinflammation after treatment with inotuzumab ozogamicin for B-cell acute lymphoblastic leukaemiaCurtis Marcoux, Pinkesh Thakkar, David M Conrad, et al.
Experimental and Molecular Pathology|September 20, 2005
Adenosine-induced apoptosis in EL-4 thymoma cells is caspase-independent and mediated through a non-classical adenosine receptorAsile El-Darahali, Helen Fawcett, Jamie S Mader, et al.
The American Journal of Dermatopathology|February 9, 2010
Primary cutaneous PEComaAnna Chaplin, David M Conrad, Cuneyt Tatlidil, et al.
International Journal of Clinical and Experimental Pathology|January 23, 2020
Mixed phenotype acute leukemia, B/myeloid, NOS with near-tetraploidy: a case reportKimberley M Nix, Karen J Harrison, Sudeep P Shivakumar, et al.
Journal of Cellular Biochemistry|April 27, 2004
Ryanodine receptor signaling is required for anti-CD3-induced T cell proliferation, interleukin-2 synthesis, and interleukin-2 receptor signalingDavid M Conrad, Elyisha A Hanniman, Carrie L Watson, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 9, 2004
Adenosine acts through A2 receptors to inhibit IL-2-induced tyrosine phosphorylation of STAT5 in T lymphocytes: role of cyclic adenosine 3',5'-monophosphate and phosphatasesHong Zhang, David M Conrad, Jared J Butler, et al.
Apoptosis : an International Journal on Programmed Cell Death|January 23, 2010
The Ca(2+) channel blocker flunarizine induces caspase-10-dependent apoptosis in Jurkat T-leukemia cellsDavid M Conrad, Suzanne J Furlong, Carolyn D Doucette, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Molecular Cancer Therapeutics|April 14, 2005
Bovine lactoferricin selectively induces apoptosis in human leukemia and carcinoma cell linesJamie S Mader, Jayme Salsman, David M Conrad, et al.
Immunology and Cell Biology|July 22, 2005
Antibody blockade of Thy-1 (CD90) impairs mouse cytotoxic T lymphocyte induction by anti-CD3 monoclonal antibodyS M Mansour Haeryfar, David M Conrad, Brucel Musgrave, et al.
International Journal of Oncology|February 23, 2008
Inhibition of T cell and natural killer cell function by adenosine and its contribution to immune evasion by tumor cells (Review)David W Hoskin, Jamie S Mader, Suzanne J Furlong, et al.
Lancet (London, England)|September 28, 2024
Bone marrow necrosis and hyperinflammation after treatment with inotuzumab ozogamicin for B-cell acute lymphoblastic leukaemiaCurtis Marcoux, Pinkesh Thakkar, David M Conrad, et al.
Experimental and Molecular Pathology|September 20, 2005
Adenosine-induced apoptosis in EL-4 thymoma cells is caspase-independent and mediated through a non-classical adenosine receptorAsile El-Darahali, Helen Fawcett, Jamie S Mader, et al.
The American Journal of Dermatopathology|February 9, 2010
Primary cutaneous PEComaAnna Chaplin, David M Conrad, Cuneyt Tatlidil, et al.
International Journal of Clinical and Experimental Pathology|January 23, 2020
Mixed phenotype acute leukemia, B/myeloid, NOS with near-tetraploidy: a case reportKimberley M Nix, Karen J Harrison, Sudeep P Shivakumar, et al.
Journal of Cellular Biochemistry|April 27, 2004
Ryanodine receptor signaling is required for anti-CD3-induced T cell proliferation, interleukin-2 synthesis, and interleukin-2 receptor signalingDavid M Conrad, Elyisha A Hanniman, Carrie L Watson, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 9, 2004
Adenosine acts through A2 receptors to inhibit IL-2-induced tyrosine phosphorylation of STAT5 in T lymphocytes: role of cyclic adenosine 3',5'-monophosphate and phosphatasesHong Zhang, David M Conrad, Jared J Butler, et al.
Apoptosis : an International Journal on Programmed Cell Death|January 23, 2010
The Ca(2+) channel blocker flunarizine induces caspase-10-dependent apoptosis in Jurkat T-leukemia cellsDavid M Conrad, Suzanne J Furlong, Carolyn D Doucette, et al.
Pageof 3